PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT •2.1 Preface •2.2 Preface •2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE •Market ecosystem •Market characteristics •Market segmentation analysis PART 04: MARKET SIZING •Market definition •Market sizing 2018 •Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS •Bargaining power of buyers •Bargaining power of suppliers •Threat of new entrants •Threat of substitutes •Threat of rivalry •Market condition PART 06: MARKET SEGMENTATION BY PRODUCT •Market segmentation by product •Comparison by product •Laboratory testing devices - Market size and forecast 2018-2023 •POC testing devices - Market size and forecast 2018-2023 •Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE •Geographic segmentation •Geographic comparison •North America - Market size and forecast 2018-2023 •Europe - Market size and forecast 2018-2023 •Asia - Market size and forecast 2018-2023 •ROW - Market size and forecast 2018-2023 •Key leading countries •Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES •Market drivers •Market challenges PART 11: MARKET TRENDS •Increasing involvement of various organizations to create awareness about STDs •Advances that enable the rapid diagnosis of STDs •Approval of drugs and strong drug pipeline PART 12: VENDOR LANDSCAPE •Overview •Landscape disruption PART 13: VENDOR ANALYSIS •Vendors covered •Vendor classification •Market positioning of vendors •Abbott Laboratories •bioMérieux SA •Bio-Rad Laboratories Inc. •Danaher Corp. •F. Hoffmann-La Roche Ltd. PART 14: APPENDIX •Research methodology •List of abbreviations •Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ billions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Laboratory testing devices - Market size and forecast 2018-2023 ($ billions) Exhibit 21: Laboratory testing devices - Year-over-year growth 2019-2023 (%) Exhibit 22: POC testing devices - Market size and forecast 2018-2023 ($ billions) Exhibit 23: POC testing devices - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2018-2023 ($ billions) Exhibit 29: North America - Year-over-year growth 2019-2023 (%) Exhibit 30: Europe - Market size and forecast 2018-2023 ($ billions) Exhibit 31: Europe - Year-over-year growth 2019-2023 (%) Exhibit 32: Asia - Market size and forecast 2018-2023 ($ billions) Exhibit 33: Asia - Year-over-year growth 2019-2023 (%) Exhibit 34: ROW - Market size and forecast 2018-2023 ($ billions) Exhibit 35: ROW - Year-over-year growth 2019-2023 (%) Exhibit 36: Key leading countries Exhibit 37: Market opportunity Exhibit 38: Impact of drivers and challenges Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Abbott Laboratories - Vendor overview Exhibit 45: Abbott Laboratories - Business segments Exhibit 46: Abbott Laboratories - Organizational developments Exhibit 47: Abbott Laboratories - Geographic focus Exhibit 48: Abbott Laboratories - Segment focus Exhibit 49: Abbott Laboratories - Key offerings Exhibit 50: bioMérieux SA - Vendor overview Exhibit 51: bioMérieux SA - Product segments Exhibit 52: bioMérieux SA - Organizational developments Exhibit 53: bioMérieux SA - Geographic focus Exhibit 54: bioMérieux SA - Key offerings Exhibit 55: Bio-Rad Laboratories Inc. - Vendor overview Exhibit 56: Bio-Rad Laboratories Inc. - Business segments Exhibit 57: Bio-Rad Laboratories Inc. - Organizational developments Exhibit 58: Bio-Rad Laboratories Inc. - Geographic focus Exhibit 59: Bio-Rad Laboratories Inc. - Segment focus Exhibit 60: Bio-Rad Laboratories Inc. - Key offerings Exhibit 61: Danaher Corp. - Vendor overview Exhibit 62: Danaher Corp. - Product segments Exhibit 63: Danaher Corp. - Organizational developments Exhibit 64: Danaher Corp. - Geographic focus Exhibit 65: Danaher Corp. - Segment focus Exhibit 66: Danaher Corp. - Key offerings Exhibit 67: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 68: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 69: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 70: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 71: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 72: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 73: Validation techniques employed for market sizing Exhibit 74: Definition of market positioning of vendors

Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and F. Hoffmann-La Roche Ltd.